Premium Tirzepatide (GIP/GLP-1 Agonist) Research Peptide UK

Welcome to the highest standard of synthetic peptides. For laboratories and academic researchers looking to buy Tirzepatide UK supplies, GB Peptides offers strictly tested, highly purified dual-agonists for advanced in-vitro studies. If you are procuring Tirzepatide UK for metabolic, glycemic control, and adipose tissue research, our batch-tested vials provide reliable consistency from sequence to sequence.

Tirzepatide is a novel, 39-amino-acid synthetic peptide engineered with a C20 fatty diacid moiety. This structural modification extends its half-life significantly, allowing for prolonged receptor engagement in long-term biochemical models.

Mechanism of Action: The Dual-Incretin Agonist

When evaluating Tirzepatide UK in biochemical research models, its ability to synergistically target two distinct incretin receptors is its defining characteristic. Tirzepatide acts as a potent, unbalanced dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.

1. GLP-1 Receptor Activation: Regulates glucose homeostasis, delays gastric emptying, and modulates appetite signaling pathways.

2. GIP Receptor Activation: Enhances the GLP-1 effect on insulin secretion while independently modulating lipid metabolism and improving white adipose tissue function.

In contemporary clinical research, the simultaneous activation of these two receptors has demonstrated profound synergistic effects. Compared to selective GLP-1 receptor agonists (like Semaglutide), dual-agonism yields superior dose-dependent reductions in both body weight and hemoglobin A1c (HbA1c) in metabolic disease models.

For foundational clinical data on how this dual-agonist outperforms single-receptor models, consult the PubMed clinical review on Tirzepatide and metabolic function. To explore its broader mechanisms involving lipid metabolism and the GIP receptor, review this NCBI publication on Dual GIP/GLP-1 Agonism.

Tirzepatide Product Specifications

To ensure accuracy and replicability in your laboratory environments, our Tirzepatide UK stock adheres to strict molecular standards. Every batch undergoes rigorous third-party High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing to guarantee $\ge$99% purity.

• Chemical Name: Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)

• Molecular Formula: $C_{225}H_{348}N_{48}O_{68}$

• Molecular Weight: $4813.5\text{ g/mol}$

• Purity (HPLC): $\ge$99.0%

• Appearance: White lyophilized solid (freeze-dried powder)

• Format: 10mg glass vial

Preparation and Storage Guidelines

Proper storage of Tirzepatide UK is essential to maintain structural stability. The lyophilized powder is highly stable at room temperature for transit but must be correctly handled upon arrival at your research facility.

• Storage (Lyophilized): Store unmixed vials in a freezer at -20°C (or below) for long-term stability up to 24 months. Avoid repeated freeze-thaw cycles.

• Reconstitution: Prior to research applications, the peptide must be reconstituted using sterile bacteriostatic water. Gently roll the vial until fully dissolved; do not shake aggressively, as this can break the delicate peptide bonds.

• Storage (Reconstituted): Once reconstituted, the solution must be kept refrigerated at 2°C to 8°C and utilized within 30 days to prevent degradation.

Mandatory Research Disclaimer

Please read carefully before purchasing:

This Tirzepatide UK product is sold exclusively for strictly controlled in-vitro and laboratory research purposes. This product is not a drug, supplement, food, or cosmetic, and it is absolutely NOT intended for human consumption or diagnostic use.

By purchasing from GB Peptides, you agree that you are a qualified researcher, and this product will be handled in compliance with all relevant UK health and safety regulations. We reserve the right to cancel any order if we suspect the product will be used outside of a sanctioned research environment.